Clinical Trial Update: Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not? [NA]

View source ↗

Summary

A clinical trial assessing whether to continue anti-TNF therapy in patients with ulcerative colitis in clinical remission has completed. The update notes comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Certolizumab pegol (certolizumab pegol)
• Golimumab (golimumab)
• Infliximab (infliximab)

Snippet

Sponsor: Helse Møre og Romsdal HF | Conditions: Colitis,Ulcerative | NA | Status: COMPLETED